See the DrugPatentWatch profile for Ropivacaine
Ropivacaine is identified in DrugBank with accession number DB00331 [1].
What kind of drug is ropivacaine?
Ropivacaine is a local anesthetic drug [1]. It is classified as an amino amide-type local anesthetic, similar in chemical structure to bupivacaine and lidocaine [2].
What is ropivacaine used for?
Ropivacaine is primarily used for local and regional anesthesia in surgical procedures and for pain management [1]. It is administered to provide numbness or loss of sensation in a specific area of the body [3]. Its uses include epidural anesthesia for surgery and labor, nerve blocks for surgery, and infiltration anesthesia for minor procedures [3].
How does ropivacaine work?
As a local anesthetic, ropivacaine works by reversibly blocking nerve impulse conduction [4]. It achieves this by binding to voltage-gated sodium channels in the nerve cell membrane, preventing the influx of sodium ions that is necessary for depolarization and nerve signal transmission [4]. This results in a localized loss of sensation [4].
What are the common side effects of ropivacaine?
Common side effects associated with ropivacaine use can include nausea, vomiting, dizziness, headache, and paresthesia (a tingling or prickling sensation) [1]. More serious adverse effects, though less common, can occur, particularly with systemic absorption or inadvertent injection into a blood vessel, and may involve the central nervous system (e.g., confusion, seizures) or the cardiovascular system (e.g., bradycardia, hypotension, arrhythmias) [5].
How is ropivacaine supplied and administered?
Ropivacaine is typically supplied as a sterile solution for injection [3]. It is available in various concentrations, often used for different types of anesthesia and pain relief [3]. Administration is done by trained healthcare professionals, either by local infiltration, nerve block, or epidural injection [3].
What is the difference between ropivacaine and bupivacaine?
Ropivacaine and bupivacaine are both amino amide local anesthetics with similar uses, but they differ in their chemical structure and pharmacological profiles [2]. Ropivacaine is the pure S-enantiomer, while bupivacaine is a racemic mixture [2]. This difference contributes to ropivacaine potentially having a lower risk of central nervous system and cardiac toxicity compared to bupivacaine at equipotent doses [2][5]. Ropivacaine also tends to have a faster onset and shorter duration of action in some applications compared to bupivacaine [2].
What are the risks associated with ropivacaine injection?
Risks associated with ropivacaine injection include local tissue damage, nerve injury, and allergic reactions [1]. Systemic toxicity is a significant concern if the drug is inadvertently injected intravenously or absorbed too rapidly into the bloodstream [5]. This can lead to symptoms affecting the central nervous and cardiovascular systems [5].
Who manufactures ropivacaine?
Ropivacaine is manufactured by several pharmaceutical companies. For instance, Fresenius Kabi markets ropivacaine hydrochloride injection under the brand name Naropin [6]. Other manufacturers also produce generic versions of ropivacaine [1].
What is the patent status of ropivacaine?
The original patents for ropivacaine have expired, allowing for the production of generic versions of the drug [7]. However, companies may hold patents on specific formulations, delivery systems, or manufacturing processes related to ropivacaine, which could impact market exclusivity for those specific innovations.
What are the clinical considerations for using ropivacaine?
Clinical considerations for ropivacaine use include careful dose selection based on the procedure and patient factors, monitoring for signs of systemic toxicity, and awareness of potential drug interactions [5]. Patients with hepatic impairment may require dose adjustments due to the drug's metabolism in the liver [1].
Sources:
[1] https://go.drugbank.com/drugs/DB00331
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394159/
[3] https://www.rxlist.com/naropin-drug.htm
[4] https://www.ncbi.nlm.nih.gov/books/NBK537072/
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896662/
[6] https://www.freseniuskabi.com/us/products/naropin
[7] https://pubmed.ncbi.nlm.nih.gov/11865679/